(Q36079507)

12 August 2017

Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma (English)

1 reference

12 August 2017

1 reference

Färkkilä M

1

1 reference

12 August 2017

Jääskeläinen J

2

1 reference

12 August 2017

Kallio M

3

1 reference

12 August 2017

Blomstedt G

4

1 reference

12 August 2017

Raininko R

5

1 reference

12 August 2017

Virkkunen P

6

1 reference

12 August 2017

Paetau A

7

1 reference

12 August 2017

Sarelin H

8

1 reference

12 August 2017

Mäntylä M

9

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

1

1 reference

12 August 2017

138-141

1 reference

Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

Modulation of T-cell function by gliomas

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

The incidence of intracranial gliomas in southern Finland.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

Selection bias in clinical trials of anaplastic glioma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

Clinical effect of interferon in malignant brain tumours.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033327

Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancer

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8018525

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1994.263

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8018525

1 reference